Whistleblowing Germany’s Bayer agrees $40m deal to resolve US whistleblower’s lawsuits iStock.com/brunocoelhopt Image John van der Luit-Drummond Editor-in-Chief Monday 05 September 2022 German pharmaceuticals giant Bayer has agreed to pay $40m to settle alleged violations of the United States’ False Claims Act in connection with three prescription drugs. Get AccessContinue reading International Employment LawyerAlready have access? Login now Email Enter your email address. Password Enter the password that accompanies your email address. Reset your passwordLog in Need access? Find out how to enjoy unlimited accessGet access You might also like... Harassment Ambulance dispatcher sexually assaulted at work, EEOC alleges Discrimination Texas harvester settles DoJ claim it discriminated against US citizens Immigration Labour-staffing boss sentenced for inducing illegal workers into Key West Health & Safety Florida utility fined $500,000 for “wilfully” violating OSHA rule leading to five deaths